273 related articles for article (PubMed ID: 27240134)
41. Clinical outcome of Iranian patients with advanced ovarian cancer with neoadjuvant chemotherapy versus primary debulking surgery.
Ghaemmaghami F; Karimi-Zarchi M; Modares-Gilani M; Mousavi A; Behtash N
Asian Pac J Cancer Prev; 2008; 9(4):719-24. PubMed ID: 19256766
[TBL] [Abstract][Full Text] [Related]
42. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
[TBL] [Abstract][Full Text] [Related]
44. Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN).
Lecointre L; Velten M; Lodi M; Saadeh R; Lavoué V; Ouldamer L; Bendifallah S; Koskas M; Bolze PA; Collinet P; Canlorbe G; Touboul C; Huchon C; Coutant C; Faller E; Boisramé T; Gantzer J; Martin D; Baldauf JJ; Akladios C; Ballester M
Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():64-72. PubMed ID: 31864157
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of advanced ovarian carcinoma: surgery before chemotherapy or chemotherapy before surgery?].
Piura B
Harefuah; 2014 Sep; 153(9):524-6, 558-9. PubMed ID: 25417488
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy.
Lee YJ; Lee IH; Kim YJ; Chung YS; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
PLoS One; 2018; 13(9):e0203366. PubMed ID: 30188915
[TBL] [Abstract][Full Text] [Related]
47. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis.
Bristow RE; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1070-6. PubMed ID: 16875720
[TBL] [Abstract][Full Text] [Related]
48. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
49. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
Eisenkop SM; Friedman RL; Wang HJ
Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
[TBL] [Abstract][Full Text] [Related]
50. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
Lee SJ; Kim BG; Lee JW; Park CS; Lee JH; Bae DS
J Obstet Gynaecol Res; 2006 Feb; 32(1):99-106. PubMed ID: 16445534
[TBL] [Abstract][Full Text] [Related]
51. Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
van Eden WJ; Kok NF; Jóźwiak K; Lahaye ML; Beets GL; van Leerdam ME; Boot H; Aalbers AG
Dis Colon Rectum; 2017 May; 60(5):477-487. PubMed ID: 28383447
[TBL] [Abstract][Full Text] [Related]
52. Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer.
Lee YY; Lee JW; Lu L; Xu W; Kollara A; Brown T; Heo EJ; May T
Int J Gynaecol Obstet; 2018 Dec; 143(3):325-332. PubMed ID: 30129040
[TBL] [Abstract][Full Text] [Related]
53. CHRONO: randomized trial of the CHROnology of surgery after Neoadjuvant chemotherapy for Ovarian cancer.
Classe JM; Ferron G; Ouldamer L; Gauthier T; Emambux S; Gladieff L; Dupre PF; Anota A
Int J Gynecol Cancer; 2022 Aug; 32(8):1071-1075. PubMed ID: 35321888
[TBL] [Abstract][Full Text] [Related]
54. [PRIMARY CYTOREDUCTIVE SURGERY VERSUS NEOADJUVANT CHEMOTHERARY IN TREATMENT OF ADVANCED OVARIAN CANCER (STAGE III C-IV). OUR AND FOREIGN EXPERIENCE].
Ivanov S; Kovachev E; Kolev N; Bechev B; Kolev N
Akush Ginekol (Sofiia); 2016; 55 Suppl 1 Pt 1():16-9. PubMed ID: 27514164
[TBL] [Abstract][Full Text] [Related]
55. Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
Seward SM; Winer I
Cancer Metastasis Rev; 2015 Mar; 34(1):5-10. PubMed ID: 25597035
[TBL] [Abstract][Full Text] [Related]
56. Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy.
Lee YJ; Kim D; Shim JE; Bae SJ; Jung YJ; Kim S; Lee H; Kim SH; Jo SB; Lee JY; Kim HS; Paik S
Int J Cancer; 2020 Apr; 146(7):1851-1861. PubMed ID: 31603993
[TBL] [Abstract][Full Text] [Related]
57. Treatment outcomes and predictive factors in patients ≥70 years old with advanced ovarian cancer.
Piedimonte S; Bernardini MQ; May T; Cybulska P; Ferguson SE; Laframboise S; Bouchard-Fortier G; Avery L; Hogen L
J Surg Oncol; 2022 Mar; 125(4):736-746. PubMed ID: 34786711
[TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.
Mueller JJ; Zhou QC; Iasonos A; O'Cearbhaill RE; Alvi FA; El Haraki A; Eriksson AG; Gardner GJ; Sonoda Y; Levine DA; Aghajanian C; Chi DS; Abu-Rustum NR; Zivanovic O
Gynecol Oncol; 2016 Mar; 140(3):436-42. PubMed ID: 26777991
[TBL] [Abstract][Full Text] [Related]
59. Does Neoadjuvant Chemotherapy Impact Prognosis in Advanced-Stage Epithelial Ovarian Cancer Optimally Debulked at Surgery?
Al Mutairi N; Le T
J Obstet Gynaecol Can; 2019 Feb; 41(2):185-190. PubMed ID: 30316718
[TBL] [Abstract][Full Text] [Related]
60. Advanced stage (IIIC/IV) endometrial cancer: Role of cytoreduction and determinants of survival.
Rajkumar S; Nath R; Lane G; Mehra G; Begum S; Sayasneh A
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():26-31. PubMed ID: 30639953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
